General Thoracic Rapid Fire Orals

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Nathaniel Evans, III, MD
Disclosure(s): Astra Zeneca: Advisory Board (Ongoing); Bristol Myers Squib: Advisory Board (Ongoing); Intuitive Surgical: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Merck: Advisory Board (Ongoing), Speaker (Ongoing)

Daniela Molena, MD
Disclosure(s): Boehringer: Consultant (Terminated, February 21, 2024)

Presentations

  1. Lung Retransplantation After Single Lung Transplantation
    Hailey A. Theeuwen, MD
     
  2. Bridging the Gap: A Comparative Analysis of Patients Requiring Mechanical Ventilation or ECMO as Bridge to Lung Transplant Between ERAS
    Ariba Moin, MD
     
  3. Updated Analysis of the Impact of Pulmonary Function Tests on Complications After Lung Resection
    Bailey Wallen, BS
     
  4. A Breath of Fresh Air: Optimizing Lungs for Transplantation Using siRNA-Based Therapies During Ex-Vivo Machine Perfusion
    Julianna E. Buchwald
     
  5. Extended Sleeve Lobectomy After Neoadjuvant Immunochemotherapy for Centrally Located Non-Small Cell Lung Cancer
    Shuben Li, MD, PhD
     
  6. Sex-Based Differences in Tumor Response to Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer
    Marisa Sewell, MD
     
  7. Comparison Between Robotic and Thoracoscopic Surgical Stapling Devices During Robotic Pulmonary Resection: Analysis of Surgical and Economic Outcomes
    Domenico Galetta, MD, PhD
Activity summary
Available credit: 
  • 0.75 ABS Accredited CME
  • 0.75 ABTS Accredited CME
  • 0.75 AMA PRA Category 1 Credit
Activity opens: 
03/01/2025
Activity expires: 
03/01/2028
Cost:
$0.00
Rating: 
0

Available Credit

  • 0.75 ABS Accredited CME
  • 0.75 ABTS Accredited CME
  • 0.75 AMA PRA Category 1 Credit

Price

Cost:
$0.00
Please login or register to take this course.

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Nathaniel Evans, III, MD
Disclosure(s): Astra Zeneca: Advisory Board (Ongoing); Bristol Myers Squib: Advisory Board (Ongoing); Intuitive Surgical: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Merck: Advisory Board (Ongoing), Speaker (Ongoing)

Daniela Molena, MD
Disclosure(s): Boehringer: Consultant (Terminated, February 21, 2024)

Presentations

  1. Lung Retransplantation After Single Lung Transplantation
    Hailey A. Theeuwen, MD
     
  2. Bridging the Gap: A Comparative Analysis of Patients Requiring Mechanical Ventilation or ECMO as Bridge to Lung Transplant Between ERAS
    Ariba Moin, MD
     
  3. Updated Analysis of the Impact of Pulmonary Function Tests on Complications After Lung Resection
    Bailey Wallen, BS
     
  4. A Breath of Fresh Air: Optimizing Lungs for Transplantation Using siRNA-Based Therapies During Ex-Vivo Machine Perfusion
    Julianna E. Buchwald
     
  5. Extended Sleeve Lobectomy After Neoadjuvant Immunochemotherapy for Centrally Located Non-Small Cell Lung Cancer
    Shuben Li, MD, PhD
     
  6. Sex-Based Differences in Tumor Response to Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer
    Marisa Sewell, MD
     
  7. Comparison Between Robotic and Thoracoscopic Surgical Stapling Devices During Robotic Pulmonary Resection: Analysis of Surgical and Economic Outcomes
    Domenico Galetta, MD, PhD